NEW YORK (GenomeWeb News) – Biotage expects to cut around 65 jobs at its Charlottesville, Va., facilities rather than the 50 it had initially estimated when it announced the layoffs in January.
A Biotage spokesperson told GenomeWeb Daily News today that the firm had around 75 employees in Charlottesville before the initial round of layoffs was announced. She said the cuts were being made in waves a few months apart.
The firm will retain around 10 employees, who will move to the firm's new US office in North Carolina in Sepember. However, the new facility will not have any production capabilities, with employees focused on administrative tasks, distribution, and sales, she said.
Uppsala, Sweden-based Biotage said in January that it would move its instrument production from its current facilities in Charlottesville to an unnamed contract manufacturer. The instruments made at that facility are primarily for purification applications. A small portion of the firm's consumables also are made at the Virginia facility, but production of those products are being moved to Biotage's facility in Cardiff, Wales, which already manufactures the majority of its consumables.